Litcius/Paper detail

Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts

Sophie I E Liem, Maaike Boonstra, Saskia le Cessie, Antonella Riccardi, Paolo Airó, Oliver Distler, Marco Matucci‐Cerinic, Cristian Caimmi, Elise Siegert, Yannick Allanore, T. Huizinga, René E. M. Toes, Hans Ulrich Scherer, Jeska K de Vries‐Bouwstra

2022The Lancet Rheumatology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAntibodyDiseaseInternal medicineImmunologySystemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts | Litcius